Novabay Pharmaceuticals Stock News

Does Insider Buying Mean A Bullish Outlook For These Penny Stocks? The post 3 Hot Penny Stocks To Buy In December According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Informati

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) CEO Justin Hall acquired 69,767 shares of NovaBay Pharmaceuticals stock in a transaction that occurred on Monday, December 6th. The shares were purchased at an average cost of $0.43 per share, with a total value of $29,999.81. The transaction was disclosed in a legal filing with the SEC, which is available []

NovaBay Pharmaceuticals, Inc. (NBY) with the stream of -6.38% also noticed, India iFresh Inc. (IFMK) encountered a rapid change of -10.71% in the last hour of trading session. NovaBay Pharmaceuticals, The post Flashy Stock: NovaBay Pharmaceuticals, Inc. (AMEX:NBY), iFresh Inc. (NASDAQ:IFMK) appeared first on Stocks Equity .

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) insider Jeffrey Kunin bought 30,000 shares of the firms stock in a transaction dated Tuesday, November 30th. The shares were acquired at an average cost of $0.46 per share, with a total value of $13,800.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is []

Hot penny stocks to watch as new virus fears emerge on Black Friday. The post Hot Penny Stocks To Buy?

BIMI International Medical Inc. (BIMI) with the stream of 0.25% also noticed, India NovaBay Pharmaceuticals, Inc. (NBY) encountered a rapid change of 6.12% in the last hour of Wednesday’s trading … The post Captivating Stock: BIMI International Medical Inc. (NASDAQ:BIMI), NovaBay Pharmaceuticals, Inc. (AMEX:NBY) appeared first on Stocks Equity .

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) saw a significant drop in short interest in the month of October. As of October 29th, there was short interest totalling 1,590,000 shares, a drop of 25.7% from the October 14th total of 2,140,000 shares. Based on an average daily volume of 895,900 shares, the days-to-cover ratio is presently 1.8 days. []

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the recipient of a significant decrease in short interest in October. As of October 29th, there was short interest totalling 1,590,000 shares, a decrease of 25.7% from the October 14th total of 2,140,000 shares. Based on an average trading volume of 895,900 shares, the short-interest ratio is currently 1.8 days. []

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research report issued on Wednesday, Zacks.com reports. The firm currently has a $0.50 price objective on the biopharmaceutical companys stock. Zacks Investment Researchs price objective indicates a potential upside of 7.67% from the stocks current price. []

Riot Blockchain, Inc. (RIOT) with the stream of -10.43% also noticed, India NovaBay Pharmaceuticals, Inc. (NBY) encountered a rapid change of -0.73% in the last hour of Tuesdays trading session. The post Hot Stock in the Spotlight: Riot Blockchain, Inc. (NASDAQ:RIOT), NovaBay Pharmaceuticals, Inc. (AMEX:NBY) appeared first on Stocks Equity .

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and []

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, missing the Zacks consensus estimate of ($0.04) by ($0.01), MarketWatch Earnings reports. NovaBay Pharmaceuticals had a negative return on equity of 64.50% and a negative net margin of 96.77%. Shares of NYSEAMERICAN:NBY opened []

NovaBay Pharmaceuticals' (NBY) CEO Justin Hall on Q3 2021 Results - Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on DERMAdoctor Acquisition - Conference Call Transcript

Are these penny stocks worth adding to your October watchlist? The post Why These Penny Stocks Deserve a Spot On Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Informa